Authors:
Oettle, H
Arning, M
Pelzer, U
Arnold, D
Stroszczynski, C
Langrehr, J
Reitzig, P
Kindler, M
Herrenberger, J
Musch, R
Korsten, FW
Huhn, D
Riess, H
Citation: H. Oettle et al., A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer, ANN ONCOL, 11(10), 2000, pp. 1267-1272
Authors:
Oettle, H
Pelzer, U
Hochmuth, K
Diebold, T
Langrehr, J
Schmidt, CA
Arning, M
Vogl, TJ
Neuhaus, P
Huhn, D
Riess, H
Citation: H. Oettle et al., Phase I trial of gemcitabine (Gemzar (R), 24 h infusion 5-fluorouracil andfolinic acid in patients with inoperable pancreatic cancer, ANTI-CANC D, 10(8), 1999, pp. 699-704
Authors:
Hintze, RE
Abou-Rebyeh, H
Adler, A
Veltzke, W
Langrehr, J
Wiedenmann, B
Neuhaus, P
Citation: Re. Hintze et al., Endoscopic therapy of ischemic-type biliary lesions [ITBL] in patients after orthotopic liver transplantation, Z GASTROENT, 37(1), 1999, pp. 13-20